Latest filing published 02 Feb 2024 for Centessa Pharmaceuticals plc, €31k.
Filing timeline
BuySaleInsider track record
Harris Rotman: trading record in brief
Harris Rotman discloses dealings in Centessa Pharmaceuticals plc to SEC (Form 4). The record holds 6 filings, for trades running from 20 September 2023 to 1 February 2024.
Every open-market trade on record is a sale: 2 sales worth €253k. Outside the open market, there are 2 share grants and 2 option exercises. Since January 2024: no purchases and 1 sale on the market.
The newest entry dates from 2 February 2024: a share grant of €31k, in Centessa Pharmaceuticals plc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Harris Rotman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,108 shares@ US$8.197.1% of flowOrdinary SharesSEC:0001847903-24-000031:1
- 4,267 shares@ US$8.107.3% of flowOrdinary SharesSEC:0001847903-24-000031:2
- 37,500 shares0Ordinary SharesSEC:0001847903-24-000031:0
- 6,234 shares@ US$3.855.1% of flowOrdinary SharesSEC:0001847903-23-000161:1
- 37,484 shares@ US$6.2950.5% of flowOrdinary SharesSEC:0001847903-23-000161:2
- 31,250 shares@ US$4.47100.0% of flowOrdinary SharesSEC:0001847903-23-000161:0
6 of 6 declarations
